Back to Drug Index
EGYPTIAN PHARMACEUTICAL DIRECTORY

AMRICARNITINE 300MG 20 F.C. TAB.

OFFICIAL RETAIL PRICE EGP 21.60
Active Molecule
L-CARNITINE
Form & Route
Oral Solid (Tablets / Capsules)
Manufacturer
AMRIYA
Therapeutic Class
ANTIOXIDANT
Commercial brands in Egypt sharing the exact same active molecule & dosage form.
Injection (Vial / Ampoule) • AMRIYA
EGP 26.40 +EGP 4.80
Injection (Vial / Ampoule) • MUP > EGYPTIAN PHARMACISTS COMPANY
EGP 80.00 +EGP 58.40
Oral Liquid (Syrup / Suspension) • MUP > EGYPTIAN PHARMACISTS COMPANY
EGP 45.90 +EGP 24.30
Injection (Vial / Ampoule) • GLOBAL NAPI PHARMACEUTICALS
EGP 135.00 +EGP 113.40
Oral Liquid (Syrup / Suspension) • GLOBAL NAPI PHARMACEUTICALS
EGP 87.00 +EGP 65.40
Oral Solid (Tablets / Capsules) • GLOBAL NAPI PHARMACEUTICALS
EGP 105.00 +EGP 83.40
General Form • EVA PHARMA
EGP 48.00 +EGP 26.40
Injection (Vial / Ampoule) • EVA PHARMA
EGP 40.00 +EGP 18.40
Oral Liquid (Syrup / Suspension) • UNISWAB > VODACHEM
EGP 86.00 +EGP 64.40
Oral Solid (Tablets / Capsules) • COPAD
EGP 250.00 +EGP 228.40
Injection (Vial / Ampoule) • MEPACO
EGP 26.40 +EGP 4.80
Oral Liquid (Syrup / Suspension) • MEPACO
EGP 70.00 +EGP 48.40
Oral Solid (Tablets / Capsules) • MEPACO
EGP 72.00 +EGP 50.40
Oral Solid (Tablets / Capsules) • > MARVEL
EGP 265.00 +EGP 243.40
General Form • FUTURE PHARMACEUTICAL INDUSTRIES (FPI)
EGP 32.40 +EGP 10.80
Oral Solid (Tablets / Capsules) • FUTURE PHARMACEUTICAL INDUSTRIES (FPI)
EGP 60.00 +EGP 38.40
Oral Liquid (Syrup / Suspension) • MARNYS > WALFARM
EGP 550.00 +EGP 528.40
Injection (Vial / Ampoule) • DELTA GRAND PHARMA > ROTABIOGEN
EGP 135.00 +EGP 113.40
Oral Solid (Tablets / Capsules) • DEBEIKY > ZAD
EGP 58.50 +EGP 36.90
Injection (Vial / Ampoule) • SUNNY MEDICAL
EGP 135.00 +EGP 113.40
Oral Solid (Tablets / Capsules) • COPAD EGYPT > DAWAA COMPANY FOR PHARMACEUTICAL INDUSTRIES
EGP 280.00 +EGP 258.40
Verified Directory Notice: Official retail pricing and commercial specifications reflect Egyptian MOH/EDA registered records. Always consult a licensed healthcare professional or pharmacist prior to modifying or substituting prescription drug treatments.

System Notice

Confirm Action